ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

September 30, 2005

Obama Signs Cigarette Tax Increase Into Law

February 13, 2009

Animal Diagnostic Lab concept OK’d

February 18, 1994

Take Program Direction Away From CCIRC, Form New Group for Clinical Trials, Conferees Suggest

June 6, 1975

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996